Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

China SXT Pharmaceuticals (SXTC) Accumulated Depreciation & Amortization (2018 - 2025)

China SXT Pharmaceuticals (SXTC) has 8 years of Accumulated Depreciation & Amortization data on record, last reported at $2.4 million in Q1 2025.

  • For Q1 2025, Accumulated Depreciation & Amortization changed 0.09% year-over-year to $2.4 million; the TTM value through Mar 2025 reached $2.4 million, changed 0.09%, while the annual FY2025 figure was $2.4 million, 0.09% changed from the prior year.
  • Accumulated Depreciation & Amortization reached $2.4 million in Q1 2025 per SXTC's latest filing, roughly flat from $2.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.4 million in Q1 2025 and bottomed at $1.5 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.0 million, with a median of $1.9 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 42.15% in 2021, then rose 0.09% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.5 million in 2021, then rose by 25.0% to $1.8 million in 2022, then grew by 5.58% to $1.9 million in 2023, then increased by 25.97% to $2.4 million in 2024, then grew by 0.09% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $2.4 million in Q1 2025, $2.4 million in Q1 2024, and $1.9 million in Q1 2023.